Swiss Regulatory Affairs

Swiss Clinical Trial Organisation (SCTO)

The Swiss Clinical Trial Organisation (SCTO) provides tools and expertise for clinical research professionals in Switzerland, focusing on regulatory affairs, data management, and project management.

The Swiss Clinical Trial Organisation (SCTO) is a nationwide network of interconnected platforms offering innovative tools and dynamic approaches for clinical research professionals. These tools are developed by experts across Switzerland in key fields, including regulatory affairs, data management, and project management, facilitating the smooth conduct of clinical study projects. The SCTO Platforms serve as pools of expertise, developing high-quality resources tailored to Swiss laws but adaptable worldwide. They aim to advance academic clinical research in Switzerland by fostering knowledge exchange and sharing best practices. The organisation is funded by the State Secretariat of Education, Research and Innovation and the Swiss National Science Foundation, with over 250 people working within its network.

About

**Who they are**
Swiss Regulatory Affairs, operating as the Swiss Clinical Trial Organisation (SCTO), is a research infrastructure of national importance in Switzerland, established to support clinical research professionals. They facilitate knowledge exchange and provide resources to ensure excellence in clinical research across the country.

**Expertise & scope**
* Develops and provides innovative tools and dynamic approaches for clinical research professionals.
* Facilitates the exchange of knowledge, resources, and best practices among experts across Switzerland.
* Focuses on key fields within clinical research, including regulatory affairs, data management, and project management.
* Supports a nationwide network of interconnected platforms comprising experts from university and cantonal hospitals, as well as the Swiss Group for Clinical Cancer Research (SAKK).
* Acts as an incubator for innovation and provides leadership in academic clinical research in Switzerland.

**Reputation / proof points**
* Operates as a research infrastructure of national importance.
* Funded by the State Secretariat for Education, Research and Innovation and the Swiss National Science Foundation.
* Has been offering services to facilitate the smooth conduct of clinical study projects since 2009.
* More than 250 people work within the CTU Network.

Additional information

The SCTO Platforms are composed of experts from various clinical trial units across Switzerland. These platforms collaborate to foster innovation and share resources globally. The organisation is funded by national bodies, underscoring its role in advancing clinical research infrastructure. Their services are designed to support the seamless execution of clinical study projects, leveraging a broad network of professionals and institutions.

Key Highlights

  • The Swiss Clinical Trial Organisation (SCTO) has been offering services to facilitate clinical study projects since 2009. Source
    “More than 250 people work in the CTU Network, which has successfully been offering services to facilitate the smooth conduct of clinical study projects since 2009.”
  • The SCTO is a research infrastructure of national importance in Switzerland. Source
    “The Swiss Clinical Trial Organisation (SCTO) is a research infrastructure of national importance funded by the State Secretariat of Education, Research and Innovation and the Swiss National Science Foundation.”
  • The organisation comprises a nationwide network of experts from clinical trial units across Switzerland. Source
    “Our platform members are located in clinical trial units at university and cantonal hospitals across Switzerland and the Swiss Group for Clinical Cancer Research (SAKK).”

Certifications & Trust Signals

  • The SCTO is funded by the State Secretariat for Education, Research and Innovation and the Swiss National Science Foundation. Source
    “The Swiss Clinical Trial Organisation (SCTO) is a research infrastructure of national importance funded by the State Secretariat of Education, Research and Innovation and the Swiss National Science Foundation.”

Buyer Snapshot

Best for
  • Academic clinical research organizations
  • Medical device innovators seeking Swiss market access
  • Research institutions requiring regulatory guidance
How engagement typically works
  • Collaborative partnership
  • Expert consultation
  • Project-specific support
Typical deliverables
  • Regulatory affairs guidance
  • Data management support
  • Project management services
  • Clinical research infrastructure access
Good to know
  • Best when engaging with academic or research-focused clinical trials.
  • Focus is on the Swiss regulatory environment.
HQ: Bern, CH
Languages: English, German, French
Timezones: Europe/Zurich
Claim status: Listed

Services & Capabilities

Best CH-REP (Swiss Authorized Rep) | Compare & Get Quotes

Jurisdictions: CH
Countries: CH
Industries: Medical devices, IVD
Portfolio: 6-25
Onboarding time: 3–10 days
Pricing model: Custom pricing
Starting from: CHF 2,000
Included services: Swissmedic contact point handling, Vigilance and incident reporting coordination, Labeling/packaging CH-REP information alignment, Mandate administration and documentation availability
Swiss Local Contact: Yes
Vigilance Contact Support: Yes
Can Be Named On Label: Yes
Swiss Entity Canton Or Region: Bern (Executive Office location)

Additional ch_rep Details

Device Classes Supported
All device classes (I, IIa, IIb, III) and IVDs
Supports MDR
false
Supports IVDR
false
Swiss Entity Canton Or Region
Bern (Executive Office location)
Labeling Support
true
Swiss Local Contact
Yes
Vigilance Contact Support
true
Can Be Named On Label
true
Request quotes
⚡ Instant booking available
Appoint a Swiss Authorized Representative (CH-REP) for Medical Devices
Compare Swiss Regulatory Affairs and other vetted providers — instant pricing, no RFQ needed.
Book now — instant pricing →
Cruxi - Regulatory Compliance Services